Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$250K
Filings
33
Firms Hired
2
Active Period
2019–2023
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
Client expense: $40,000 · Firm income: —
Matched citations: H.R. 2401
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
Client expense: $40,000 · Firm income: —
Matched citations: H.R. 2401
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
Client expense: $40,000 · Firm income: —
Matched citations: S. 1249
Issues related to public and private investment in biosciences and R&D S. 1249, American Innovation Act H.R. 2401, American Cures Act
Client expense: $40,000 · Firm income: —
Matched citations: S. 1249
Source: Senate LDA